Explore how an innovative medicine moves from approval to patient access.
Selected market
Malaysia
NPRA evaluates products for DCA registration. MOH facility access follows a separate FUKKM assessment, listing and implementation pathway. University/military and private access require confirmation of their own institutional and payer arrangements.
NPRA / DCA
MOH Pharmacy Programme
MOH committees
MOH
MOH facilities
5 decision nodes14 cited sources
For education only — not regulatory, pricing or legal advice.
